Company Cyber Security Posture
NANA
NA Company Details
NA
NA
NA
NA
NA
NA
Scan still pending
NA
NA

Between 200 and 800
This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.

.png)

Company Scoring based on AI Models
Model Name | Date | Description | Current Score Difference | Score |
---|---|---|---|---|
AVERAGE-Industry | 03-12-2025 | This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers. | N/A | Between 200 and 800 |
Company Cyber Security News & History
Entity | Type | Severity | Impact | Seen | Url ID | Details | View |
---|
Company Subsidiaries

NA
Access Data Using Our API

Get company history
.png)
NA Cyber Security News
Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week
Shares in Verve Therapeutics (NASDAQ: VERV) soared 80.5% this week on the news of an agreement for Eli Lilly (NYSE: LLY) to acquire Verve. Theย ...
Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a pushย ...
Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion
Eli Lilly agreed to acquire Verve Therapeutics for $1 billion upfront, adding a cardiovascular disease treatment to its portfolio. The purchaseย ...
Beyond Obesity: Eli Lillyโs Genetic Medicine Bet On Verve Therapeutics
Eli Lilly's $1.3 billion acquisition of Verve Therapeutics represents a strategic move into cardiovascular genetic medicine.
Eli Lilly lands "bargain" deal to acquire Verve Therapeutics for $1.3bn
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn.
Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to boost its pipeline ofย ...
Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve
World's biggest drugmaker clinches $1.3bn deal as it hunts for experimental treatments to boost its pipeline.
Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say
Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday.
Eli Lilly (NYSE:LLY) Eyes US$1.3 Billion Acquisition Of Verve Therapeutics
Eli Lilly (NYSE:LLY) recently saw its stock price rise by 6.63% over the last month, a movement potentially influenced by significant eventsย ...

NA Similar Companies

Avantor
Avantorยฎ is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

bioMรฉrieux
A family-owned company, bioMรฉrieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v

Jabatan Pertanian Malaysia
Jabatan Pertanian adalah salah sebuah agensi di bawah Kementerian Pertanian dan Industri Asas Tani. Core Bussiness bagi Jabatan Pertanian adalah Aktiviti Pengembangan kepada petani dan usahawan tani. Ibu Pejabat Jabatan Pertanian terletak di Prsint 4, Wisma Tani, Putrajaya dan juga terdapat Pejabat

Thermo Fisher Scientific
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,

Gilead Sciences
At Gilead, we set โ and achieve โ bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt

Amgen
Amgen harnesses the best of biology and technology to fight the worldโs toughest diseases, and make peopleโs lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond whatโs

Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
NA CyberSecurity History Information
How many cyber incidents has NA faced?
Total Incidents: According to Rankiteo, NA has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at NA?
Incident Types: The types of cybersecurity incidents that have occurred include .
Additional Questions
What Do We Measure?
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
